NEW BRUNSWICK, N.J., Dec. 27 (HSMN NewsFeed) — Johnson & Johnson (NYSE: JNJ ) today announced that stockholders of Omrix Biopharmaceuticals, Inc. (Nasdaq: OMRI ; "Omrix") tendered approximately 16,749,152 shares of Omrix common stock, includin…
Biopharmaceuticals, Mergers & Acquisitions
Johnson & Johnson, Omrix Biopharmaceuticals

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Johnson and Johnson Completes Delicate Offer for Omrix Biopharmaceuticals, Inc.”
Leave a Comment